Skip to main content

Table 1 Basic characteristics of included patients in the whole exome sequencing

From: The genomic and transcriptome characteristics of lung adenocarcinoma patients with previous breast cancer

ID

Age (lung)

Age (breast)

Interval (months)

Family history of malignant tumors

TNM stage (lung)

Location (lung)

TNM stage (breast)

Location (breast)

ER

PR

HER-2

Chemotherapy

Radiotherapy

2,000,808

49

48

15

no

IA

right

IIIC

left

+

+

2+

yes

yes

2,001,331

44

41

40

no

IA

left

IA

right

+

+

2+

yes

no

2,001,347

45

44

10

yes

IA

right

IA

left

+

+

–

no

no

2,001,364

53

45

90

no

IA

left

IA

left

±

–

–

yes

no

2,001,589

31

31

6

no

IA

left

IA

left

+

+

3+

no

no

2,001,704

46

45

7

no

IA

right

IA

left

+

+

3+

yes

no

2,001,705

50

46

44

no

IA

left

IIA

left

–

–

+

no

no

2,002,120

66

61

60

yes

IA

left

IIA

right

–

–

3+

yes

no

2,002,259

55

53

28

no

IA

right

IIIC

left

+

–

3+

yes

yes

2,002,297

64

61

42

no

IA

right

IA

right

–

–

2+

yes

no

2,001,631

52

–

–

no

IA

left

–

–

–

–

–

–

–

2,001,701

70

–

–

no

IA

right

–

–

–

–

–

–

–

2,001,703

54

–

–

no

IA

right

–

–

–

–

–

–

–

2,002,031

57

–

–

yes

IA

left

–

–

–

–

–

–

–

2,002,191

48

–

–

no

IA

left

–

–

–

–

–

–

–

2,002,298

44

–

–

yes

IA

right

–

–

–

–

–

–

–

2,002,388

67

–

–

no

IA

right

–

–

–

–

–

–

–

2,002,414

55

–

–

no

IA

left

–

–

–

–

–

–

–

2,002,560

68

–

–

no

IA

left

–

–

–

–

–

–

–

2,002,561

64

–

–

no

IA

right

–

–

–

–

–

–

–

  1. TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor; HER-2: human epidermal growth factor receptor-2